Evidence map›Paper›PMID 40623990›Full record

ArticleNature communications2025

Early detection of emerging SARS-CoV-2 Variants from wastewater through genome sequencing and machine learning.

Xiaowei Zhuang, Van Vo, Michael A Moshi, Ketan Dhede, Nabih Ghani, Shahraiz Akbar, Ching-Lan Chang, Angelia K Young, Erin Buttery, William Bendik and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Xiaowei Zhuang *Laboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
Van Vo *Laboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.ORCID http://orcid.org/0000-0003-4273-4312
Michael A MoshiLaboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
Ketan DhedeLaboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.ORCID http://orcid.org/0009-0009-4126-6255
Nabih GhaniLaboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.ORCID http://orcid.org/0000-0001-5940-6310
Shahraiz AkbarLaboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
Ching-Lan ChangLaboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.ORCID http://orcid.org/0009-0005-9926-9038
Angelia K YoungSouthern Nevada Health District, Las Vegas, NV, USA.ORCID http://orcid.org/0009-0000-6140-4226
Erin ButterySouthern Nevada Health District, Las Vegas, NV, USA.
William BendikSouthern Nevada Health District, Las Vegas, NV, USA.ORCID http://orcid.org/0000-0001-9686-8485
Hong ZhangSouthern Nevada Health District, Las Vegas, NV, USA.
Salman AfzalSouthern Nevada Health District, Las Vegas, NV, USA.
Duane MoserDivision of Hydrologic Sciences, Desert Research Institute, Las Vegas, NV, USA.ORCID http://orcid.org/0000-0003-2825-5753
Dietmar CordesCleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.
Cassius LockettSouthern Nevada Health District, Las Vegas, NV, USA. lockett@snhd.org.
Daniel GerritySouthern Nevada Water Authority, P.O. Box 99954, Las Vegas, NV, USA. daniel.gerrity@snwa.com.
Horng-Yuan KanSouthern Nevada Health District, Las Vegas, NV, USA. kan@snhd.org.
Edwin C OhLaboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA. edwin.oh@unlv.edu.ORCID http://orcid.org/0000-0002-6042-1478

Funding

Outreach/Diversity/Pipeline ProjectP20GM103440 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Eduardo A Robleto · 2012 to 2026
$58.0M
Machine and deep learning for finding multimodal imaging biomarkers in prodromal ADRF1AG071566 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI CORDES, DIETMAR, LOWE, MARK J · 2021 to 2021
$2.3M
Linking Ciliary Biology to the Functional Annotation of Psychiatric DistordersR01MH109706 · NIMH · UNIVERSITY OF NEVADA LAS VEGAS · PI OH, EDWIN C. · 2016 to 2020
$1.9M
Machine and deep learning for finding multimodal imaging biomarkers in prodromal ADR01AG071566 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI CORDES, DIETMAR, LOWE, MARK J · 2024 to 2025
$1.6M
Genomic Surveillance of Mpox through the Development of a Wastewater Intelligence Model and Data Analytics PlatformR21AI194218 · NIAID · UNIVERSITY OF NEVADA LAS VEGAS · PI OH, EDWIN C. · 2025 to 2025
$417k
Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) GM103440Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) MH109706NIAID NIH HHS R21 AI194218NIA NIH HHS R01 AG071566NIA NIH HHS RF1 AG071566NIGMS NIH HHS P20 GM103440NIMH NIH HHS R01 MH109706U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC) NH75OT000057-01-00
6 · The paper itself

Abstract

Genome sequencing from wastewater enables accurate and cost-effective identification of SARS-CoV-2 variants. However, existing computational pipelines have limitations in detecting emerging variants not yet characterized in humans. Here, we present an unsupervised learning approach that clusters co-varying and time-evolving mutation patterns to identify SARS-CoV-2 variants. To build our model, we sequence 3659 wastewater samples collected over two years from urban and rural locations in Southern Nevada. We then develop a multivariate independent component analysis (ICA)-based pipeline to transform mutation frequencies into independent sources. These data-driven time-evolving and co-varying sources are compared to 8810 SARS-CoV-2 clinical genomes from Nevadans. Our method accurately detects the Delta variant in late 2021, Omicron variants in 2022, and emerging recombinant XBB variants in 2023. Our approach also reveals the spatial and temporal dynamics of variants in both urban and rural regions; achieves earlier detection of most variants compared to other computational tools; and uncovers unique co-varying mutation patterns not associated with any known variant. The multivariate nature of our pipeline boosts statistical power and supports accurate early detection of SARS-CoV-2 variants. This feature offers a unique opportunity to detect emerging variants and pathogens, even in the absence of clinical testing.

Indexed as

COVID-19Genome, ViralMachine LearningSARS-CoV-2WastewaterHumansMutationWhole Genome SequencingWastewater

Identifiers

PMID40623990
PMCPMC12234891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.